Literature DB >> 31465735

Microbiota determines insulin sensitivity in TLR2-KO mice.

Dioze Guadagnini1, Guilherme Zweig Rocha1, Andrey Santos1, Heloisa Balan Assalin1, Sandro Massao Hirabara2, Rui Curi2, Alexandre Gabarra Oliveira3, Patricia O Prada4, Mario J A Saad5.   

Abstract

INTRODUCTION: Environmental factors have a key role in the control of gut microbiota and obesity. TLR2 knockout (TLR2-/-) mice in some housing conditions are protected from diet-induced insulin resistance. However, in our housing conditions these animals are not protected from diet-induced insulin-resistance. AIM: The aim of the present study was to investigate the influence of our animal housing conditions on the gut microbiota, glucose tolerance and insulin sensitivity in TLR2-/- mice.
MATERIAL AND METHODS: The microbiota was investigated by metagenomics, associated with hyperinsulinemic euglycemic clamp and GTT associated with insulin signaling through immunoblotting.
RESULTS: The results showed that TLR2-/- mice in our housing conditions presented a phenotype of metabolic syndrome characterized by insulin resistance, glucose intolerance and increase in body weight. This phenotype was associated with differences in microbiota in TLR2-/- mice that showed a decrease in the Proteobacteria and Bacteroidetes phyla and an increase in the Firmicutesphylum, associated with and in increase in the Oscillospira and Ruminococcus genera. Furthermore there is also an increase in circulating LPS and subclinical inflammation in TLR2-/-. The molecular mechanism that account for insulin resistance was an activation of TLR4, associated with ER stress and JNK activation. The phenotype and metabolic behavior was reversed by antibiotic treatment and reproduced in WT mice by microbiota transplantation.
CONCLUSIONS: Our data show, for the first time, that the intestinal microbiota can induce insulin resistance and obesity in an animal model that is genetically protected from these processes.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Genetic protection; Gut microbiota; Insulin resistance; LPS; TLR2

Mesh:

Substances:

Year:  2019        PMID: 31465735     DOI: 10.1016/j.lfs.2019.116793

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  5 in total

1.  Gut Bacteria Selectively Altered by Sennoside A Alleviate Type 2 Diabetes and Obesity Traits.

Authors:  Zhonghong Wei; Peiliang Shen; Peng Cheng; Yin Lu; Aiyun Wang; Zhiguang Sun
Journal:  Oxid Med Cell Longev       Date:  2020-06-25       Impact factor: 6.543

2.  Spirulina platensis alleviates chronic inflammation with modulation of gut microbiota and intestinal permeability in rats fed a high-fat diet.

Authors:  Ting Yu; Yan Wang; Xiaosu Chen; Wenjie Xiong; Yurong Tang; Lin Lin
Journal:  J Cell Mol Med       Date:  2020-07-07       Impact factor: 5.310

3.  Structural and Functional Modulation of Gut Microbiota by Jiangzhi Granules during the Amelioration of Nonalcoholic Fatty Liver Disease.

Authors:  Rui-Rui Wang; Lin-Fang Zhang; Lu-Ping Chen; Jian-Ying Wang; Lei Zhang; Yue-Song Xu; Pei-Lin Yang; Guang Ji; Bao-Cheng Liu
Journal:  Oxid Med Cell Longev       Date:  2021-12-20       Impact factor: 7.310

Review 4.  Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus.

Authors:  Zheng Zhou; Bao Sun; Dongsheng Yu; Chunsheng Zhu
Journal:  Front Cell Infect Microbiol       Date:  2022-02-15       Impact factor: 5.293

5.  Baricitinib counteracts metaflammation, thus protecting against diet-induced metabolic abnormalities in mice.

Authors:  Debora Collotta; William Hull; Raffaella Mastrocola; Fausto Chiazza; Alessia Sofia Cento; Catherine Murphy; Roberta Verta; Gustavo Ferreira Alves; Giulia Gaudioso; Francesca Fava; Magdi Yaqoob; Manuela Aragno; Kieran Tuohy; Christoph Thiemermann; Massimo Collino
Journal:  Mol Metab       Date:  2020-05-13       Impact factor: 7.422

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.